Martin Hund

3.8k total citations · 2 hit papers
48 papers, 2.6k citations indexed

About

Martin Hund is a scholar working on Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health and Immunology. According to data from OpenAlex, Martin Hund has authored 48 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Obstetrics and Gynecology, 29 papers in Pediatrics, Perinatology and Child Health and 15 papers in Immunology. Recurrent topics in Martin Hund's work include Pregnancy and preeclampsia studies (31 papers), Birth, Development, and Health (22 papers) and Reproductive System and Pregnancy (14 papers). Martin Hund is often cited by papers focused on Pregnancy and preeclampsia studies (31 papers), Birth, Development, and Health (22 papers) and Reproductive System and Pregnancy (14 papers). Martin Hund collaborates with scholars based in Switzerland, Germany and Spain. Martin Hund's co-authors include Holger Stepan, Manu Vatish, Deirdre Allegranza, Maria Schoedl, Peter Dilba, Stefan Verlohren, Frédéric Chantraine, Elisa Llurba, Harald Zeisler and Anne Cathrine Staff and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Hypertension.

In The Last Decade

Martin Hund

46 papers receiving 2.6k citations

Hit Papers

Predictive Value of the sFlt-1:PlGF Ratio in Women with S... 2016 2026 2019 2022 2016 2022 250 500 750 1000

Peers

Martin Hund
Veronica Giorgione United Kingdom
W. Heyl Germany
Deirdre Allegranza Switzerland
Jonathan Hyett Australia
Martin Hund
Citations per year, relative to Martin Hund Martin Hund (= 1×) peers Lisbeth Vercruysse

Countries citing papers authored by Martin Hund

Since Specialization
Citations

This map shows the geographic impact of Martin Hund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Hund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Hund more than expected).

Fields of papers citing papers by Martin Hund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Hund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Hund. The network helps show where Martin Hund may publish in the future.

Co-authorship network of co-authors of Martin Hund

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Hund. A scholar is included among the top collaborators of Martin Hund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Hund. Martin Hund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Laven, Joop S.E., et al.. (2024). ANTI-MÜLLERIAN HORMONE TO DETERMINE POLYCYSTIC OVARIAN MORPHOLOGY: A SUB-ANALYSIS OF THE APHRODITE STUDY IN AN ASIAN POPULATION. Fertility and Sterility. 122(4). e411–e411. 1 indexed citations
3.
Stepan, Holger, Alberto Galindo, Martin Hund, et al.. (2023). Clinical Utility of sFlt-1 and PlGF in Screening, Prediction, Diagnosis and Monitoring of Pre-eclampsia and Fetal Growth Restriction. Obstetrical & Gynecological Survey. 78(8). 451–453. 16 indexed citations
4.
Gao, Jinsong, Xianghua Huang, Wen Di, et al.. (2021). Short-Term Prediction of Preeclampsia in Chinese Women Using the Soluble fms-Like Tyrosine Kinase 1/Placental Growth Factor Ratio: A Sub-Analysis of the PROGNOSIS Asia Study. Frontiers in Cardiovascular Medicine. 8. 602560–602560. 2 indexed citations
5.
Hund, Martin, et al.. (2021). Antimüllerian hormone to determine polycystic ovarian morphology. Fertility and Sterility. 116(4). 1149–1157. 35 indexed citations
6.
Anckaert, Ellen, et al.. (2019). Evaluation of the Elecsys® anti-Müllerian hormone assay for the prediction of hyper-response to controlled ovarian stimulation with a gonadotrophin-releasing hormone antagonist protocol. European Journal of Obstetrics & Gynecology and Reproductive Biology. 236. 133–138. 9 indexed citations
7.
Schlembach, Dietmar, et al.. (2019). Diagnostic utility of angiogenic biomarkers in pregnant women with suspected preeclampsia: A health economics review. Pregnancy Hypertension. 17. 28–35. 18 indexed citations
8.
Huhn, Evelyn A., Andreas Schoetzau, Begoña Martínez de Tejada, et al.. (2018). Diagnostic Accuracy of Different Soluble fms-Like Tyrosine Kinase 1 and Placental Growth Factor Cut-Off Values in the Assessment of Preterm and Term Preeclampsia: A Gestational Age Matched Case-Control Study. Frontiers in Medicine. 5. 325–325. 13 indexed citations
9.
Schlembach, Dietmar, et al.. (2018). Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany. BMC Health Services Research. 18(1). 603–603. 53 indexed citations
10.
Gaccioli, Francesca, Ulla Sovio, Emma Cook, et al.. (2018). Screening for fetal growth restriction using ultrasound and the sFLT1/PlGF ratio in nulliparous women: a prospective cohort study. The Lancet Child & Adolescent Health. 2(8). 569–581. 91 indexed citations
11.
Zeisler, Harald, Elisa Llurba, Frédéric Chantraine, et al.. (2016). Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia. Obstetrics and Gynecology. 128(2). 261–269. 57 indexed citations
12.
Zeisler, Harald, Elisa Llurba, Frédéric Chantraine, et al.. (2016). Predictive Value of the sFlt-1. Obstetrical & Gynecological Survey. 71(5). 273–274. 6 indexed citations
13.
Klein, Evelyn, Dietmar Schlembach, A Ramoni, et al.. (2016). Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia. PLoS ONE. 11(5). e0156013–e0156013. 58 indexed citations
14.
Calle, María de la, Juan Luis Delgado⋈, Stefan Verlohren, et al.. (2016). 59 Gestational age-specific reference ranges for the sFlt-1/PlGF ratio in multiple pregnancies. Pregnancy Hypertension. 6(3). 165–166. 1 indexed citations
15.
Zeisler, Harald, Elisa Llurba, Frédéric Chantraine, et al.. (2016). Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. New England Journal of Medicine. 374(1). 13–22. 1114 indexed citations breakdown →
16.
Anderson, Richard A., Ellen Anckaert, Ernesto Bosch, et al.. (2015). Prospective study into the value of the automated Elecsys antimüllerian hormone assay for the assessment of the ovarian growing follicle pool. Fertility and Sterility. 103(4). 1074–1080.e4. 62 indexed citations
17.
Hund, Martin, et al.. (2015). Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia – the PreOS study protocol. Hypertension in Pregnancy. 34(1). 102–115. 25 indexed citations
18.
Hund, Martin, Deirdre Allegranza, Maria Schoedl, et al.. (2014). Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy and Childbirth. 14(1). 324–324. 63 indexed citations
19.
Merki‐Feld, Gabriele S. & Martin Hund. (2010). Clinical experience with the combined contraceptive vaginal ring in Switzerland, including a subgroup analysis of previous hormonal contraceptive use. The European Journal of Contraception & Reproductive Health Care. 15(6). 413–422. 16 indexed citations
20.
Hahne, Penelope, et al.. (2003). SWAP-70 Identifies a Transitional Subset of Actin Filaments in Motile Cells. Molecular Biology of the Cell. 14(8). 3242–3253. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026